Phenylketonuria (PKU)
Condition Description
Phenylketonuria (PKU) is an autosomal recessive disease caused by mutations in the phenylalanine hydroxylase (PAH) gene. Loss-of-function mutations in PAH, the rate-limiting enzyme in phenylalanine (Phe) catabolism, lead to the neurotoxic accumulation of Phe. Toxic Phe concentrations cause intellectual disability (in children), cognitive impairment, psychiatric disease, attention deficit disorders, epilepsy, depression, anxiety, and behavioral problems (de Groot 2009).
Status
Active and Recruiting Patients
Active Trials
-
SPONSOR: JNANA
INDICATION: Phenylketonuria (PKU)
PROTOCOL: JNT-517-101
PHASE: 1/1b
DESCRIPTION: A Phase 1, First-in-Human, Multiple Part, Single Ascending and Multiple Dose Study of JNT-517 in Healthy Participants and in Participants with Phenylketonuria
STATUS: Recruiting
RECRUITING PATIENTS: Yes
Inquire About Trial →
Past Trials
-
SPONSOR:
INDICATION:
PROTOCOL:
PHASE:
DESCRIPTION:
STATUS:
RECRUITING PATIENTS: Yes
Inquire About Trial →